Category Archives: healthcare
Are US and Canadian Rx Policies Converging?
by Tom Norton
As the US pharmaceutical industry anxiously watches the rapid onset of Obamacare, certainly one of the more pressing issues is the debate over the number of drugs that will be reimbursed in each therapeutic class under the Essential Health Benefits (EHB) program. To say that this is a critical concern for the future [...]
Also posted in Global, Guest Blog, Legal, Market Access, Strategy Tagged Affordable Care Act, Canada, essential health benefits, health insurance, HHS, Medicare, Obamacare Leave a comment
Congress, FDA Should Consider Tech Solutions for Safer Compounding
By Niels Erik Hansen
Last fall’s deadly meningitis outbreak linked to contaminated steroid injections is a tragic reminder of the risk of errors inherent in manual pharmacy medication compounding. Unsanitary conditions at the Massachusetts compounding pharmacy that made the injections resulted in fungal contamination of the drugs. The resulting outbreak sickened nearly 700 people in [...]
Also posted in Guest Blog, Manufacturing, Regulatory, Safety, Technology, compliance Tagged compounded drugs, compounding pharmacies, Congress, FDA, Pharmacy Leave a comment
Sequestration: How Big a Hit for FDA, Research and Pharma?
The greatly feared federal budget sequestration mandate went into effect March 1, and, initially, the impact was fairly muted. The stock market soared, employment rose and government workers continued on their jobs. Federal agencies, including the Food and Drug Administration (FDA), launched initiatives to comply with the mandated 5% across-the-board cut in spending (in reality [...]
Also posted in FDA, Legal, R&D, leadership Tagged Capitol Hill, CDC, NIH, Politics, sequestration, Sequestration Act, United States Congress, White House Leave a comment
Changing the DNA of Pharma Patient Adherence Programs
by Grant Corbett
Epigenetics is the study of changes in human gene expression, in particular from environmental factors. Pharma is also experiencing epigenetic change. Human genes are formed from DNA, which are instructions much like a blueprint. Similarly, the environment is changing pharmaceutical DNA and how brand marketing is instructed.
Also posted in E-Media, Marketing, Patient Communication, compliance, patient compliance, patient education Tagged adherence, CBI, compliance, health literacy, Marketing, patient adherence, patient compliance 3 Comments

Healthcare Systems in Europe "Failing Patients"